MedPath

The Coping With and Caring for Infants With Special Needs Intervention in Down Syndrome Infants

Not Applicable
Recruiting
Conditions
Family
Physical Disability
Down Syndrome
Registration Number
NCT06197035
Lead Sponsor
University of Seville
Brief Summary

The objective is to compare the impact of standard infant physical therapy and the family-centered program, Coping with and Caring for Infants with Special Needs (COPCA), on infants born with Down syndrome. This is a randomized controlled trial that will be carried out in the patients' homes and outpatient settings in Spain between January 2024 and March 2024. An evaluation battery will be used that includes child and family outcomes and video analysis of therapy sessions.

The Infant Motor profile will be the primary outcome instrument.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Babies with Down syndrome
  • Families involved in Pediatric Physical Therapy
Exclusion Criteria
  • Other associated developmental disorders
  • To not speak Spanish
  • Do not sign informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Motor Development3-6-18 months.

INFANT MOTOR PROFILE Results achieved between the 10% and 90% percentiles indicate adequate motor development. Results between the 5% and 10% percentiles indicate a risk for delays or problems in gross motor development.

Secondary Outcome Measures
NameTimeMethod
Family empowerment3-6-18 months

Family Empowerment Scale

There are 28 items to be answered by the family with these options:

1= Strongly Agree' 2= Agree' 3= Disagree' 4= Strongly Disagree. The higher the score, the greater the empowerment.

Trial Locations

Locations (1)

University of Seville

🇪🇸

Sevilla, Spain

University of Seville
🇪🇸Sevilla, Spain
Piñero Pinto, PhD
Contact
+34655108763
epinero@us.es

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.